Thu, September 23, 2021
Wed, September 22, 2021
Tue, September 21, 2021

Nathan Weinstein Maintained (CDTX) at Strong Buy with Decreased Target to $160 on, Sep 22nd, 2021

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-decreased-target-to-160-on-sep-22nd-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Nathan Weinstein of Aegis Capital, Maintained "Cidara Therapeutics, Inc." (CDTX) at Strong Buy with Decreased Target from $180 to $160 on, Sep 22nd, 2021.

Nathan, nor any peers, have made any analyst calls on CDTX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30